SCHEMBL28809681

SCHEMBL28809681

CC(C(=O)OI)c1ccccc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCL8 P10145 8/20 0.71
▸ TTR P02766 4/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ TBXA2R P21731 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PTGS2 P35354 7/20 0.45
▸ PTGS1 P23219 3/20 0.45
▸ AKR1B10 O60218 2/20 0.45
▸ ABCB11 O95342 2/20 0.45
▸ UGT1A9 O60656 1/20 0.45
▸ TRPA1 O75762 1/20 0.45
▸ MT-CO2 P00403 1/20 0.45
▸ ALB P02768 1/20 0.45
▸ UGT1A6 P19224 1/20 0.45
▸ UGT1A1 P22309 1/20 0.45
▸ CXCR1 P25024 1/20 0.45
▸ ADRA1A P35348 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3151521 0.83 CXCL8 (1.00) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL3137707 0.83 CXCL8 (1.00) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL12129515 0.83 CXCL8 (1.00) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL11515988 0.78 CXCL8 (0.62) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL8371915 0.77 CXCL8 (0.61) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL2739297 0.76 CXCL8 (0.67) CXCL8TTRCYP2C9LMNAPTGS2
SCHEMBL11516024 0.75 CXCL8 (0.58) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL7126780 0.75 CXCL8 (0.82) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL7716835 0.74 CXCL8 (0.73) CXCL8TTRCYP2C9TBXA2RMAPK1
SCHEMBL11403823 0.74 CXCL8 (0.73) CXCL8TTRCYP2C9TBXA2RMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109608436-A Substituted Methylformyl reagent and the method for improving compound physical chemistry and/or pharmacokinetic property using the reagent 斯法尔制药私人有限公司 2019-04-12 — — CN disclosed
CN-103607888-A Substituted methyl formyl reagents and methods of using the same to improve physicochemical and/or pharmacokinetic properties of compounds SPHAERA PHARMA PRIVATE LTD 2014-02-26 — — CN disclosed
Send feedback